Our group previously found other biomarkers of cervical cancer, such as p16 (Stiasny et al. 2017), MDM2 (Stiasny et al. 2017), galectin-3 (Stiasny et al. 2017), H3K9ac (Beyer et al. 2017) and H3K4me3 (Beyer et al. 2017). This evidence concerns the gene MDM2 and cervical carcinoma.